VEGFA and cancer: Furthermore, the combination of OXP and β-Sit enhances the inhibitory effect on angiogenesis by diminishing VEGF-A levels and inhibiting β-catenin and NF-κB-p65, thereby preventing the proliferation and viability of resistant cancer cells.